Related Experiment Video
Updated: Aug 3, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
We can't afford to turn a blind eye to myopia
C M Bourke1,2, J Loughman3, D I Flitcroft2
1From the Ophthalmology Department, The Mater Misericordiae University Hospital, Eccles Street, Inns Quay, Dublin D07R2WY, Ireland.
Background:
Myopia is becoming increasingly prevalent throughout the world. It is an overlooked but leading cause of blindness, particularly among the working aged population. Myopia is often considered benign because it is easily corrected with glasses, contact lenses or refractive surgery. Traditionally myopia has been classified into physiological and pathological subtypes based on the degree of myopia present. Higher levels of myopia are associated with increased risk of pathological complications but it is important to note that there is no safe level of myopia. Even low levels of myopia increase the risk of retinal detachment and other ocular comorbidities which will be discussed in detail later. The most serious complication, myopic maculopathy, is the only leading cause of blindness without an established treatment and therefore leads to inevitable loss of vision in some myopes, even at a young age.
Aim:
To highlight the current myopia epidemic and the sight threatening complications associated with it.
Design:
This is a commissioned review article. Data were gathered by performing a literature review, searching the PubMed database for recent articles regarding myopia.
Conclusions:
Myopia is a potentially blinding disease. By identifying at risk individuals and intervening before they become myopic, eye care practitioners can prevent or delay spectacle use, reduce the risk of the myriad of myopic complications, thereby improve the patient's quality of life and positively impact its socio-economic effects.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Accessory Structures of the Eye
Focusing of Light in the Eye
Photoreceptors and Visual Pathways

